Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
IPO Bone Therapeutics yields 32.2 million euro

Bone Therapeutics – a Walloon cell therapy company specialized in bone fracture repair and prevention – shifts up a gear and raises 32.2 million e…


Bone Therapeutics grows both locally and internationally to become a champion of bone regenerative medicine

Walloon bone cell therapy company, Bone Therapeutics (BOTHE), is moving into their new headquarters in Gosselies. The new 3000m² facility is part …


Novartis takes license on Celyad's allogeneic CAR T cells

Celyad, a leader in the discovery and development of cell therapies, today announced a non-exclusive license agreement with Novartis for Celyad’s …

POPULAR TAGS

Jackpot for TiGenix' sepsis research

Written by DS on in the category news with the tags , .


The biotech company TiGenix gets financial support in his search for a cure for severe sepsis due to pneumonia. The European Commission granted the Leuven-based company and its partners an amount of 5.4 million euros.

TiGenix is currently working on Cx611, a suspension of stem cells derived from adipose tissue that should be applied intravenously as a treatment for sepsis with organ failure, caused by severe pneumonia.

Up to now, there is no adequate treatment for severe sepsis. Treatment is mainly symptomatically with anti-inflammatory drugs and antibiotics. TiGenix refers to the current treatment as 'palliative and supportive care'.

For this project, TiGenix partners with different research institutes from different countries. The grant is intended to fund a Phase II clinical study on nearly 180 patients.

The European Commission provides the grant through its Horizon 2020 plan, which aims to stimulate innovation and research in Europe. The project of TiGenix is one of the few clinical projects in Europe that acquired funds in this way.

Read more about: , .

RELATED ARTICLES
IPO Bone Therapeutics yields 32.2 million euro

Bone Therapeutics – a Walloon cell therapy company specialized in bone fracture repair and prevention – shifts up a gear and raises 32.2 million e…


Bone Therapeutics grows both locally and internationally to become a champion of bone regenerative medicine

Walloon bone cell therapy company, Bone Therapeutics (BOTHE), is moving into their new headquarters in Gosselies. The new 3000m² facility is part …


Novartis takes license on Celyad's allogeneic CAR T cells

Celyad, a leader in the discovery and development of cell therapies, today announced a non-exclusive license agreement with Novartis for Celyad’s …

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Turnstone KU Leuven Biowin Flanders.bio XpandInnovation V-Bio Ventures Itera Life Science UGent GSK Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.